ANDA 88391, held by Strides Pharma Intl. Hydralazine Hydrochloride.
As of Nov 16, 2026, ANDA 88391 (Hydralazine Hydrochloride), held by Strides Pharma Intl, was first approved by FDA on Sep 27, 1983, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 27, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydralazine Hydrochloride100MG ยท tablet;oral | Hydralazine Hydrochloride | Discontinued |
| Dec 11, 2001 | Supplement 11Labeling | Approved | None posted |
| Nov 4, 1988 | Supplement 10Labeling | Approved | None posted |
| Jul 14, 1988 | Supplement 9Labeling | Approved | None posted |
| May 15, 1986 | Supplement 2Manufacturing | Approved | None posted |
| Sep 27, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters